Hepatitis B Vaccines

Infectious Diseases
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

VBI Vaccines
VBI VaccinesMA - Cambridge
2 programs
2
Hepatitis B VaccinationPhase 31 trial
Hepatitis B VaccinationPhase 31 trial
Active Trials
NCT03408730CompletedEst. Oct 2019
NCT03393754CompletedEst. Apr 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
VBI VaccinesHepatitis B Vaccination
VBI VaccinesHepatitis B Vaccination

Clinical Trials (2)

NCT03408730VBI VaccinesHepatitis B Vaccination

Lot-to-lot Consistency of Sci-B-Vac™ in Adults

Start: Dec 2017Est. completion: Oct 2019
Phase 3Completed
NCT03393754VBI VaccinesHepatitis B Vaccination

Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults

Start: Dec 2017Est. completion: Apr 2019
Phase 3Completed

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space